TORONTO, ON / ACCESSWIRE / September 18, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announced that an inte... Read More...

TORONTO, ON / ACCESSWIRE / September 13, 2023 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders, today announced that Singula... Read More...

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE:HUGE) (FRA:0K9) (the “Company” or “FSD”) announced today that the board of directors had terminated the employment of the Company’s Chief Executive Officer, Dr. Raza Bokhari for cause. As previously disclosed by the Company, Dr. Bokhari was placed on administrative leave fol... Read More...

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE) (“FSD Pharma” or the “Company”) today announces the following corporate updates. Corporate Update The Company continues to pursue its strategy of completing a Phase 2 clinical trial for the use of its lead compound, ultramicronized-palmitoylethanolamide (or ultramicron... Read More...

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced the closing of previously announced definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 3,454,543 Shares (collectively, the “... Read More...

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (Nasdaq: HUGE) (“FSD Pharma” or the “Company”), today announced that it has entered into definitive agreements with investors for the purchase and sale of 4,318,179 Class B Subordinate Voting Shares of the Company (“Shares”) and warrants to purchase 3,454,543 Shares (collectively, the “Securities”... Read More...

All subjects completed the trial per protocol, no safety concerns found up to the highest dose tested of 2400 mg/dayFSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma") today announced favorable topline results from its Phase 1 randomized, double-blind, placebo-controlled study of ultramicronized palmitoylethanolamide ... Read More...

TORONTO , June 3, 2020 - FSD Pharma Inc. (HUGE.CN) (HUGE.CN) (0K9A.F) ("FSD Pharma") today announced that the U.S. Food and Drug Administration (FDA) has given the company permission to submit an Investigational New Drug Application (IND) for the use of FSD-201 (ultramicronized palmitoylethanolamide, or ultramicronized PEA) to treat COVID... Read More...

Toronto, Ontario--(Newsfile Corp. - June 2, 2020) - PharmaDrug Inc. (CSE: BUZZ) (OTC: LMLLF) (the "Company" or "PharmaDrug") is pleased to announce that it has appointed global cannabis industry pioneer and founder of Aurora Cannabis Inc. (NYSE: ACB) ("Aurora"), Terry Booth, as the Chairman of its advisory board focussing on the Company's... Read More...

- Buyer Holds Option to Purchase Additional Shares - TORONTO, May 21, 2020 - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced the sale of 5.0 million common shares of Pharmadrug Inc. (CSE: BUZZ) (formerly Aura Health) in a privately negotiated transaction at C$0.08 per share for ca... Read More...

Revenue increase of 133% from March 2020Gross profit increase of 257% from March 2020Pretax net income increase of 527% from March 2020VANCOUVER, BC / ACCESSWIRE / May 14, 2020 / World-Class Extractions Inc. (CSE:PUMP)(WCF.F)(OTCQB:WCEXF) (the "Company" or "World-Class") is pleased to report that its subsidiary, Pineapple Express Delivery... Read More...

TORONTO, March 23, 2020 - FSD Pharma Inc. (Nasdaq: HUGE) (CSE: HUGE.CN) (FRA: 0K9A) ("FSD Pharma" or the "Company") today announced that it has taken steps to mitigate the impact of the novel coronavirus SARS-CoV-2 pandemic on its wholly-owned subsidiary, FV Pharma Inc. ("FV Pharma"), a licensed producer under Canada's Cannabis Act and Re... Read More...

VANCOUVER, British Columbia, Feb. 13, 2020 -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that, pursuant to a directors’ resolution,  it will change its name to Icanic Brands Company Inc. There will be no... Read More...

Phoenix, Arizona--(Newsfile Corp. - February 11, 2020) - The Stock Day Podcast welcomed FSD Pharma (NASDAQ: HUGE) (the Company"), a specialty biotech pharmaceutical R&D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocannabinoid system of the human body to treat certain d... Read More...

Integrated Cannabis Settles an Aggregate of $12,500,000 in Outstanding DebtVANCOUVER, British Columbia, Feb. 11, 2020 -- Integrated Cannabis Company, Inc. (CSE: ICAN, OTCQB: ICNAF) (“Integrated Cannabis” or the “Company”), a multi-state brand operator in California and Nevada, is pleased to announce that it has entered into an amending ag... Read More...

FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma") and Solarvest BioEnergy Inc. (TSX-V: SVS) ("Solarvest") (collectively, the "Parties"), are pleased to announce that, further to their press release of May 7, 2019, the Parties have agreed to amendments to the Collaborative Research and Development Agreement (the "Resear... Read More...

TORONTO--(BUSINESS WIRE)--Insert in second paragraph, first sentence of release: Executive Co-Chairman and CEO. The corrected release reads: FSD PHARMA TO COMMENCE TRADING ON NASDAQ CAPITAL MARKET UNDER SYMBOL ‘HUGE’ - Management to Present at Biotech Showcase 2020 - FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9) (“FSD Ph... Read More...

TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) (“FSD Pharma”) announces that Nasdaq has approved its application to have its Class B Subordinate Voting Shares (the “Shares”) listed on the Nasdaq Capital Market (“Nasdaq”). FSD Pharma expects the Shares to commence trading on Nasdaq in the near future. Abo... Read More...

HighlightsGanja Gold products now in 275 dispensaries across California;Proprietary pre-roll manufacturing technology ready for production runs;Brand licensing opportunities being explored in California, Nevada and Michigan;Nevada launch of Ganja Gold being ramped up;Mr. Suhas Patel, LLM, JD. has been appointed to the Board of Directors a... Read More...